Back to Results
First PageMeta Content
Nephrogenic systemic fibrosis / Nephrology / Gadodiamide / Gadopentetic acid / Gadolinium / Magnetic resonance imaging / Hepatorenal syndrome / Gadoteridol / Contrast medium / Chemistry / Matter / Medicine


Microsoft Word - DDR letter - final with signatures[removed]mcm.doc
Add to Reading List

Open Document

File Size: 79,55 KB

Share Result on Facebook

City

Rockville / Gadolinium / /

Company

MultiHance Omniscan OptiMARK ProHance Sponsor Bayer HealthCare Pharmaceuticals Inc. / M.D. / Bayer HealthCare Pharmaceuticals Inc. / Group Medical / GE Healthcare Mallinckrodt Inc. / Product Magnevist Omniscan Sponsor Bayer HealthCare Pharmaceuticals Inc. / GE Healthcare OptiMARK Mallinckrodt Inc. / Regulatory Affairs GE Healthcare Mallinckrodt Inc. / Bracco Diagnostics Inc. / ProHance Bracco Diagnostics Inc. / /

Facility

These pharmacy / /

IndustryTerm

magnetic resonance imaging / healthcare / imaging / /

MedicalCondition

disease / chronic severe renal insufficiency / chronic / dysfunction / acute renal insufficiency / renal insufficiency / Nephrogenic Systemic Fibrosis / hepatorenal syndrome / syndrome / FIBROSIS / /

MedicalTreatment

hemodialysis / /

Organization

National Science Foundation / U.S. Food and Drug Administration / /

Person

Paul MacCarthy / Alberto Spinazzi / Pharmacovigilance Herbert Neuman / Larry Bell / /

/

Position

Vice President / Vice President / Head / Head / /

Product

Omniscan / OptiMARK / Magnevist / ProHance / MultiHance / /

ProvinceOrState

Maryland / /

Technology

magnetic resonance imaging / transplantation / MRI / /

URL

www.accessdata.fda.gov / http /

SocialTag